J Findlow
Overview
Explore the profile of J Findlow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vazquez J, Taha M, Findlow J, Gupta S, Borrow R
Epidemiol Infect
. 2016 Jul;
144(14):3052-3057.
PMID: 27357022
The Global Meningococcal Initiative (GMI) is an international group of scientists and clinicians with recognized expertise in meningococcal disease including microbiology, immunology, epidemiology, public health and vaccinology. The GMI was...
2.
Ladhani S, Ramsay M, Flood J, Campbell H, Slack M, Pebody R, et al.
Euro Surveill
. 2012 Nov;
17(46).
PMID: 23171823
A national seroprevalence study was performed to determine the prevalence of Haemophilus influenzae type b (Hib) antibodies in England and Wales in 2009, when Hib disease incidence was the lowest...
3.
Clarke E, Williams N, Dull P, Findlow J, Borrow R, Finn A, et al.
Mucosal Immunol
. 2012 Jul;
6(2):288-96.
PMID: 22806100
Colonization of the nasopharyngeal mucosa by meningococcus and other polysaccharide (PS)-encapsulated bacteria precedes invasion. PS-conjugate vaccines induce PS-specific B-cell memory (B(MEM)) and also prevent colonization, thus blocking person-to-person transmission, generating...
4.
Lear S, Eren E, Findlow J, Borrow R, Webster D, Jolles S
J Clin Pathol
. 2006 Oct;
59(11):1191-3.
PMID: 17071803
The current treatment of primary antibody deficiency (PAD) is the early recognition of the condition and replacement immunoglobulin combined with prompt treatment of infections and complications. The route of administration...
5.
Richmond P, Borrow R, Findlow J, Martin S, Thornton C, Cartwright K, et al.
Infect Immun
. 2001 Mar;
69(4):2378-82.
PMID: 11254596
The polysaccharide capsule of serogroup C Neisseria meningitidis (MenC) has been integral to vaccine development. Licensed MenC vaccines contain the O-acetylated (OAc+) form of polysaccharide. Some MenC strains have de-O-acetylated...
6.
Richmond P, Borrow R, Goldblatt D, Findlow J, Martin S, Morris R, et al.
J Infect Dis
. 2000 Nov;
183(1):160-3.
PMID: 11078484
To test for immunologic memory after a single dose of meningococcal C conjugate (MCC) vaccine in toddlers, 226 children 12-18 months old were randomized to receive 1 of 3 MCC...
7.
Borrow R, Fox A, Richmond P, Clark S, Sadler F, Findlow J, et al.
Epidemiol Infect
. 2000 Sep;
124(3):427-32.
PMID: 10982066
The induction of immunological memory to serogroup A and C polysaccharides in UK infants immunized with three doses of a meningococcal A/C oligosaccharide CRM197 conjugate vaccine was investigated. Forty UK...
8.
Borrow R, Richmond P, Kaczmarski E, Iverson A, Martin S, Findlow J, et al.
FEMS Immunol Med Microbiol
. 2000 Apr;
28(1):79-85.
PMID: 10767611
In the UK, a co-ordinated series of phase II studies is being undertaken with meningococcal serogroup C conjugate (MCC) vaccines. The use of meningococcal A/C polysaccharide (MACP) vaccines in control...
9.
Richmond P, Kaczmarski E, Borrow R, Findlow J, Clark S, McCann R, et al.
J Infect Dis
. 2000 Feb;
181(2):761-4.
PMID: 10669372
Widespread use of meningococcal AC polysaccharide (MACP) vaccines has raised concerns about induction of hyporesponsiveness to C polysaccharide. Whether meningococcal C conjugate (MCC) vaccine overcomes any immunologic refractoriness following MACP...